Payne, Carter J.
Gupta, Urvi
Maatouk, Christopher M.
Kuo, Blanche L. http://orcid.org/0000-0001-9227-9560
Perkins, Scott W. http://orcid.org/0000-0001-6197-9476
Singh, Rishi P. http://orcid.org/0000-0001-5859-8162
Talcott, Katherine E.
Article History
Received: 13 October 2022
Revised: 16 January 2024
Accepted: 15 February 2024
First Online: 6 March 2024
Competing interests
: RPS reports personal fees from Genentech/Roche, Alcon, Novartis, Regeneron, Asclepix, Gyroscope, Bausch and Lomb, and Apellis. KET reports personal fees from Genentech/Roche, and research fees from Zeiss and Regenxbio.